Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
1PFE | Milan | EUR | Real-time | |
PFE | TradeGate | EUR | Delayed | |
PFE | Frankfurt | EUR | Delayed | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | B3 | BRL | Delayed | |
PFE | Vienna | EUR | Real-time | |
PFE | Ukraine | UAH | Delayed | |
PFE_KZ | KASE | USD | Delayed | |
PFE_KZTQKD | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Neutral | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Buy | BUY | Strong Sell | Sell | Sell |
Summary | Strong Buy | Neutral | Strong Sell | Strong Sell | Neutral |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Engulfing Bearish | 1M | 1 | Jan 23 | ||
Bullish Engulfing | 1W | 4 | Jan 29, 2023 | ||
Abandoned Baby Bullish | 5H | 4 | Feb 27, 2023 18:00 | ||
Advance Block Bearish | 1H | 4 | Feb 28, 2023 20:00 | ||
Gravestone Doji | 1H | 4 | Feb 28, 2023 20:00 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NYSE | 27.75 | 27.75 | 27.77 | 39,959,506 | -0.11% | USD | |||
Mexico | 460.13 | 460.50 | 461.10 | 74,514 | +0.03% | MXN | |||
Milan | 25.70 | 0.00 | 0.00 | 1,568 | -0.19% | EUR | |||
TradeGate | 25.75 | 25.70 | 25.75 | 0 | +0.00% | EUR | |||
Frankfurt | 26.00 | 25.70 | 25.75 | 0 | +0.00% | EUR | |||
Hamburg | 25.80 | 25.70 | 25.75 | 0 | 0.00% | EUR | |||
Xetra | 25.850 | 25.850 | 25.850 | 97,758 | +0.39% | EUR | |||
Santiago | 26.92 | 0.00 | 0.00 | 90 | 0.00% | USD | |||
Buenos Aires | 7,536.00 | 7,536.00 | 7,550.00 | 15,106 | -0.77% | ARS | |||
B3 | 34.90 | 34.78 | 35.00 | 3,243 | +0.49% | BRL | |||
Vienna | 25.350 | 25.350 | 25.450 | 0 | 0.00% | EUR | |||
Ukraine | 1,014.00 | 0.00 | 0.00 | 2 | -7.23% | UAH | |||
KASE | 27.90 | 27.66 | 27.89 | 33 | +0.87% | USD | |||
KASE | 27.67 | 27.62 | 28.19 | 0 | 0.00% | USD | |||
Colombia | 106,400.00 | 0.00 | 0.00 | 196 | -1.15% | COP | |||
Lima | 27.50 | 0.00 | 0.00 | 1,800 | -1.50% | USD |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
DMCI | 11.360 | 12.160 | 11.360 | -0.840 | -6.89% | 12.66M | |||
Cebu Landmasters | 2.800 | 2.800 | 2.780 | 0.000 | 0.00% | 537.00K | |||
Citicore Energy REIT | 2.79 | 2.81 | 2.79 | 0.00 | 0.00% | 0 | |||
GT Capital | 704.00 | 706.00 | 686.00 | +14.00 | +2.03% | 109.93K | |||
Metropolitan Bank | 65.15 | 65.20 | 64.85 | -0.05 | -0.08% | 2.30M | |||
Semirara Mining | 34.90 | 35.20 | 34.90 | -0.10 | -0.29% | 3.14M | |||
MREIT | 13.00 | 13.00 | 12.82 | +0.02 | +0.15% | 2.34M | |||
LT Group | 9.990 | 9.990 | 9.840 | +0.090 | +0.91% | 2.76M | |||
Ayala Land | 32.250 | 32.550 | 31.800 | +0.200 | +0.62% | 30.79M | 27/03 | ||
AREIT, | 35.20 | 35.50 | 35.10 | -0.30 | -0.85% | 341.50K |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review